Bessemer Group
BNR

Bessemer Group’s Burning Rock Biotech BNR Stock Holding History

Bessemer Group’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,044
Closed -$1.49M – 1659
2021
Q2 		$1.49M Buy
+5,044
New +$1.49M ﹤0.01% 360

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bessemer Group's BNR Position: Q3 2021 in Review

Bessemer Group sold out of Burning Rock Biotech (BNR) in Q3 2021, closing a stake of 5,044 shares — an estimated $1.49M sold.

Bessemer Group first reported a position in BNR in Q2 2021 and held it in 1 quarter. The position peaked at $1.49M in Q2 2021. 86 funds tracked by Wall St. Rank hold BNR as of Q3 2021.

  • Bessemer Group reported no remaining Burning Rock Biotech position as of Q3 2021 after selling out during the quarter.
  • Bessemer Group sold 5,044 Burning Rock Biotech shares in Q3 2021, an estimated $1.49M.
  • Bessemer Group first reported a position in Burning Rock Biotech in Q2 2021 and held it in 1 quarter.
  • Bessemer Group's Burning Rock Biotech position peaked at $1.49M in Q2 2021.
  • 86 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2021.

Based on Bessemer Group's 13F filing for Q3 2021, filed 12 Nov 2021.